{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:19:02Z","timestamp":1778077142844,"version":"3.51.4"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,6]]},"DOI":"10.7759\/cureus.108360","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T13:54:16Z","timestamp":1778075656000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe Hyponatremic Encephalopathy Induced by Unsupervised \u201cTherapeutic\u201d 3,4-Methylenedioxymethamphetamine Use in a 55-Year-Old Woman: A Diagnostic Pitfall"],"prefix":"10.7759","author":[{"given":"Pierre-Henri","family":"Woitrin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Lievens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881106063268","article-title":"MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress","volume":"20","author":"Parrott AC","year":"2006","unstructured":"Parrott AC. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress. J Psychopharmacol. 2006, 20:147-63. 10.1177\/0269881106063268","journal-title":"J Psychopharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02080508","article-title":"The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney","volume":"3","author":"Campbell GA","year":"2008","unstructured":"Campbell GA, Rosner MH. The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney. Clin J Am Soc Nephrol. 2008, 3:1852-60. 10.2215\/CJN.02080508","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.45278","article-title":"Oxytocin and the role of fluid restriction in MDMA-induced hyponatremia: a secondary analysis of 4 randomized clinical trials","volume":"7","author":"Atila C","year":"2024","unstructured":"Atila C, Straumann I, Vizeli P, et al.. Oxytocin and the role of fluid restriction in MDMA-induced hyponatremia: a secondary analysis of 4 randomized clinical trials. JAMA Netw Open. 2024, 7:e2445278. 10.1001\/jamanetworkopen.2024.45278","journal-title":"JAMA Netw Open"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/17470910802649470","article-title":"Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration","volume":"4","author":"Dumont GJ","year":"2009","unstructured":"Dumont GJ, Sweep FC, van der Steen R, et al.. Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Soc Neurosci. 2009, 4:359-66. 10.1080\/17470910802649470","journal-title":"Soc Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell JM","year":"2021","unstructured":"Mitchell JM, Bogenschutz M, Lilienstein A, et al.. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med. 2021, 27:1025-33. 10.1038\/s41591-021-01336-3","journal-title":"Nat Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/00001888-200308000-00003","article-title":"The importance of cognitive errors in diagnosis and strategies to minimize them","volume":"78","author":"Croskerry P","year":"2003","unstructured":"Croskerry P. The importance of cognitive errors in diagnosis and strategies to minimize them. Acad Med. 2003, 78:775-80. 10.1097\/00001888-200308000-00003","journal-title":"Acad Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu040","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia","volume":"29 Suppl 2","author":"Spasovski G","year":"2014","unstructured":"Spasovski G, Vanholder R, Allolio B, et al.. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant. 2014, 29 Suppl 2:i1-i39. 10.1093\/ndt\/gfu040","journal-title":"Nephrol Dial Transplant"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp2210411","article-title":"The syndrome of inappropriate antidiuresis","volume":"389","author":"Adrogu\u00e9 HJ","year":"2023","unstructured":"Adrogu\u00e9 HJ, Madias NE. The syndrome of inappropriate antidiuresis. N Engl J Med. 2023, 389:1499-509. 10.1056\/NEJMcp2210411","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/486996-severe-hyponatremic-encephalopathy-induced-by-unsupervised-therapeutic-34-methylenedioxymethamphetamine-use-in-a-55-year-old-woman-a-diagnostic-pitfall","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T13:54:26Z","timestamp":1778075666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/486996-severe-hyponatremic-encephalopathy-induced-by-unsupervised-therapeutic-34-methylenedioxymethamphetamine-use-in-a-55-year-old-woman-a-diagnostic-pitfall"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.108360","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,6]]}}}